This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation CAR & T Cell Therapies

LAST CHANCE: REGISTER BY MAY 20 TO SAVE UP TO $300

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
June 14-16, 2022
Delivered as a Hybrid EventIntercontinental Mark Hopkins Hotel, San Francisco, California

Laurent Poirot
SVP Immunology at Cellectis, France

Profile

Laurent Poirot obtained his PhD in Immunology with professors MATHIS and BENOIST (Harvard Medical School), studying autoimmune diabetes.

As a postdoc (GNF, San Diego), he developed high-throughput genome-wide studies in lymphocytes.

In 2009, he joined Cellectis where he developed gene editing tools for HSCs and allogenic CAR T-cells. In 2013, he became Head of Early Discovery and in 2020, SVP Immunology. His team develops innovative tools to improve immunotherapies based on gene-edited CAR T cells.

Agenda Sessions

  • T Cell Engineering for Improved Safety & Efficacy

    10:15am